<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39062017</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>28</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Respiratory SARS-CoV-2 Infection Causes Skeletal Muscle Atrophy and Long-Lasting Energy Metabolism Suppression.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1443</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines12071443</ELocationID><Abstract><AbstractText>Muscle fatigue represents the most prevalent symptom of long-term COVID, with elusive pathogenic mechanisms. We performed a longitudinal study to characterize histopathological and transcriptional changes in skeletal muscle in a hamster model of respiratory SARS-CoV-2 infection and compared them with influenza A virus (IAV) and mock infections. Histopathological and bulk RNA sequencing analyses of leg muscles derived from infected animals at days 3, 30, and 60 post-infection showed no direct viral invasion but myofiber atrophy in the SARS-CoV-2 group, which was accompanied by persistent downregulation of the genes related to myofibers, ribosomal proteins, fatty acid &#x3b2;-oxidation, tricarboxylic acid cycle, and mitochondrial oxidative phosphorylation complexes. While both SARS-CoV-2 and IAV infections induced acute and transient type I and II interferon responses in muscle, only the SARS-CoV-2 infection upregulated TNF-&#x3b1;/NF-&#x3ba;B but not IL-6 signaling in muscle. Treatment of C2C12 myotubes, a skeletal muscle cell line, with combined IFN-&#x3b3; and TNF-&#x3b1; but not with IFN-&#x3b3; or TNF-&#x3b1; alone markedly impaired mitochondrial function. We conclude that a respiratory SARS-CoV-2 infection can cause myofiber atrophy and persistent energy metabolism suppression without direct viral invasion. The effects may be induced by the combined systemic interferon and TNF-&#x3b1; responses at the acute phase and may contribute to post-COVID-19 persistent muscle fatigue.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Homma</LastName><ForeName>Sachiko T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Department of Neurology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA 02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xingyu</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-9097-9627</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Hospital for Special Surgery, New York, NY 10021, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frere</LastName><ForeName>Justin J</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0002-7514-8873</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gower</LastName><ForeName>Adam C</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0002-6122-7511</Identifier><AffiliationInfo><Affiliation>Clinical and Translational Science Institute, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA 02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jingsong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, TX 76010, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Jean K</ForeName><Initials>JK</Initials><Identifier Source="ORCID">0000-0002-4572-6417</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>tenOever</LastName><ForeName>Benjamin R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Grossman School of Medicine, New York University, New York, NY 10016, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Lan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hospital for Special Surgery, New York, NY 10021, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 AR081655</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM146636</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>5R21AR081655-02</GrantID><Agency>National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases</Agency><Country/></Grant><Grant><GrantID>UL1TR001430</GrantID><Agency>National Institutes of Health, Clinical and Translational Science Award</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">energy metabolism</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">interferons</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">muscle atrophy</Keyword><Keyword MajorTopicYN="N">muscle fatigue</Keyword><Keyword MajorTopicYN="N">tumor necrosis factor-alpha</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>27</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>27</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>27</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39062017</ArticleId><ArticleId IdType="pmc">PMC11275164</ArticleId><ArticleId IdType="doi">10.3390/biomedicines12071443</ArticleId><ArticleId IdType="pii">biomedicines12071443</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bull-Otterson L., Baca S., Saydah S. Post&#x2013;COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and &#x2265;65 years&#x2014;United States, March 2020&#x2013;November 2021. MMWR Morb. Mortal. Wkly. Rep. 2022;71:713&#x2013;717. doi: 10.15585/mmwr.mm7121e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7121e1</ArticleId><ArticleId IdType="pmc">PMC9368731</ArticleId><ArticleId IdType="pubmed">35925799</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Ayuzo Del Valle N.C., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. Long-COVID in children and adolescents: A systematic review and meta-analyses. Sci. Rep. 2022;12:9950. doi: 10.1038/s41598-022-13495-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13495-5</ArticleId><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir. Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S., Merad M. Pathological sequelae of long-haul COVID. Nat. Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L., Kannapadi N.V., Briggs J., Seal S.M., Battaglini D., Fanning J., Suen J., Robba C., Fraser J., Cho S.M. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J. Neurol. Sci. 2022;434:120162. doi: 10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-Month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Yao Q., Gu X., Wang Q., Ren L., Wang Y., Hu P., Guo L., Liu M., Xu J., et al. 1-Year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet. 2021;398:747&#x2013;758. doi: 10.1016/S0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:1644. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V., Beer R., Schiefecker A.J., Lindner A., Kofler M., Ianosi B.A., Mahlknecht P., Heim B., Peball M., Carbone F., et al. Neurological outcomes 1 year after COVID-19 diagnosis: A prospective longitudinal cohort study. Eur. J. Neurol. 2022;29:1685&#x2013;1696. doi: 10.1111/ene.15307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15307</ArticleId><ArticleId IdType="pmc">PMC9111823</ArticleId><ArticleId IdType="pubmed">35239247</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucuk A., Cumhur Cure M., Cure E. Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis. Clin. Rheumatol. 2020;39:2103&#x2013;2104. doi: 10.1007/s10067-020-05178-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05178-1</ArticleId><ArticleId IdType="pmc">PMC7249985</ArticleId><ArticleId IdType="pubmed">32458242</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares M.N., Eggelbusch M., Naddaf E., Gerrits K.H.L., van der Schaaf M., van den Borst B., Wiersinga W.J., van Vugt M., Weijs P.J.M., Murray A.J., et al. Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of COVID-19. J. Cachexia Sarcopenia Muscle. 2022;13:11&#x2013;22. doi: 10.1002/jcsm.12896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12896</ArticleId><ArticleId IdType="pmc">PMC8818659</ArticleId><ArticleId IdType="pubmed">34997689</ArticleId></ArticleIdList></Reference><Reference><Citation>Hejb&#xf8;l E.K., Harbo T., Agergaard J., Madsen L.B., Pedersen T.H., &#xd8;stergaard L.J., Andersen H., Schr&#xf8;der H.D., Tankisi H. Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: Evidence of skeletal muscle histopathology. Eur. J. Neurol. 2022;29:2832&#x2013;2841. doi: 10.1111/ene.15435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15435</ArticleId><ArticleId IdType="pmc">PMC9348124</ArticleId><ArticleId IdType="pubmed">35661354</ArticleId></ArticleIdList></Reference><Reference><Citation>Colosio M., Brocca L., Gatti M.F., Neri M., Crea E., Cadile F., Canepari M., Pellegrino M.A., Polla B., Porcelli S., et al. Structural and functional impairments of skeletal muscle in patients with postacute sequelae of SARS-CoV-2 infection. J. Appl. Physiol. 2023;135:902&#x2013;917. doi: 10.1152/japplphysiol.00158.2023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00158.2023</ArticleId><ArticleId IdType="pubmed">37675472</ArticleId></ArticleIdList></Reference><Reference><Citation>Appelman B., Charlton B.T., Goulding R.P., Kerkhoff T.J., Breedveld E.A., Noort W., Offringa C., Bloemers F.W., van Weeghel M., Schomakers B.V., et al. Muscle abnormalities worsen after post-exertional malaise in long COVID. Nat. Commun. 2024;15:17. doi: 10.1038/s41467-023-44432-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-44432-3</ArticleId><ArticleId IdType="pmc">PMC10766651</ArticleId><ArticleId IdType="pubmed">38177128</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoagland D.A., M&#xf8;ller R., Uhl S.A., Oishi K., Frere J., Golynker I., Horiuchi S., Panis M., Blanco-Melo D., Sachs D., et al. Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity. Immunity. 2021;54:557&#x2013;570.e555. doi: 10.1016/j.immuni.2021.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.01.017</ArticleId><ArticleId IdType="pmc">PMC7846242</ArticleId><ArticleId IdType="pubmed">33577760</ArticleId></ArticleIdList></Reference><Reference><Citation>Horiuchi S., Oishi K., Carrau L., Frere J., M&#xf8;ller R., Panis M., tenOever B.R. Immune memory from SARS-CoV-2 infection in hamsters provides variant-independent protection but still allows virus transmission. Sci. Immunol. 2021;6:eabm3131. doi: 10.1126/sciimmunol.abm3131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abm3131</ArticleId><ArticleId IdType="pubmed">34699266</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere J.J., Serafini R.A., Pryce K.D., Zazhytska M., Oishi K., Golynker I., Panis M., Zimering J., Horiuchi S., Hoagland D.A., et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci. Transl. Med. 2022;14:eabq3059. doi: 10.1126/scitranslmed.abq3059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq3059</ArticleId><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Quiros P.M., Goyal A., Jha P., Auwerx J. Analysis of mtDNA/nDNA ratio in mice. Curr. Protoc. Mouse Biol. 2017;7:47&#x2013;54. doi: 10.1002/cpmo.21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpmo.21</ArticleId><ArticleId IdType="pmc">PMC5335900</ArticleId><ArticleId IdType="pubmed">28252199</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A., Davis C.A., Schlesinger F., Drenkow J., Zaleski C., Jha S., Batut P., Chaisson M., Gingeras T.R. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15&#x2013;21. doi: 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA. 2005;102:15545&#x2013;15550. doi: 10.1073/pnas.0506580102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0506580102</ArticleId><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Oklejewicz M., Pen I., Durieux G.C., Daan S. Maternal and pup genotype contribution to growth in wild-type and tau mutant Syrian hamsters. Behav. Genet. 2001;31:383&#x2013;391. doi: 10.1023/A:1012274419184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1012274419184</ArticleId><ArticleId IdType="pubmed">11720124</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiaffino S., Reggiani C. Fiber types in mammalian skeletal muscles. Physiol. Rev. 2011;91:1447&#x2013;1531. doi: 10.1152/physrev.00031.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00031.2010</ArticleId><ArticleId IdType="pubmed">22013216</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch C.J., Xu Y., Hajnal A., Salzberg A.C., Kawasawa Y.I. RNA sequencing reveals a slow to fast muscle fiber type transition after olanzapine infusion in rats. PLoS ONE. 2015;10:e0123966. doi: 10.1371/journal.pone.0123966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0123966</ArticleId><ArticleId IdType="pmc">PMC4404103</ArticleId><ArticleId IdType="pubmed">25893406</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J., Zhai B., Gygi S.P., Goldberg A.L. mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy. Proc. Natl. Acad. Sci. USA. 2015;112:15790&#x2013;15797. doi: 10.1073/pnas.1521919112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1521919112</ArticleId><ArticleId IdType="pmc">PMC4703015</ArticleId><ArticleId IdType="pubmed">26669439</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodine S.C., Latres E., Baumhueter S., Lai V.K., Nunez L., Clarke B.A., Poueymirou W.T., Panaro F.J., Na E., Dharmarajan K., et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science. 2001;294:1704&#x2013;1708. doi: 10.1126/science.1065874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1065874</ArticleId><ArticleId IdType="pubmed">11679633</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Malta C., Cinque L., Settembre C. Transcriptional regulation of autophagy: Mechanisms and diseases. Front. Cell Dev. Biol. 2019;7:114. doi: 10.3389/fcell.2019.00114.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2019.00114</ArticleId><ArticleId IdType="pmc">PMC6614182</ArticleId><ArticleId IdType="pubmed">31312633</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercellino I., Sazanov L.A. The assembly, regulation and function of the mitochondrial respiratory chain. Nat. Rev. Mol. Cell Biol. 2022;23:141&#x2013;161. doi: 10.1038/s41580-021-00415-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00415-0</ArticleId><ArticleId IdType="pubmed">34621061</ArticleId></ArticleIdList></Reference><Reference><Citation>Popov L.D. Mitochondrial biogenesis: An update. J. Cell. Mol. Med. 2020;24:4892&#x2013;4899. doi: 10.1111/jcmm.15194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.15194</ArticleId><ArticleId IdType="pmc">PMC7205802</ArticleId><ArticleId IdType="pubmed">32279443</ArticleId></ArticleIdList></Reference><Reference><Citation>VanderVeen B.N., Fix D.K., Carson J.A. Disrupted skeletal muscle mitochondrial dynamics, mitophagy, and biogenesis during cancer cachexia: A role for inflammation. Oxid. Med. Cell. Longev. 2017;2017:3292087. doi: 10.1155/2017/3292087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/3292087</ArticleId><ArticleId IdType="pmc">PMC5530417</ArticleId><ArticleId IdType="pubmed">28785374</ArticleId></ArticleIdList></Reference><Reference><Citation>Romanello V., Sandri M. Mitochondrial biogenesis and fragmentation as regulators of muscle protein degradation. Curr. Hypertens. Rep. 2010;12:433&#x2013;439. doi: 10.1007/s11906-010-0157-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11906-010-0157-8</ArticleId><ArticleId IdType="pubmed">20967516</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang H., Ward W.F. PGC-1alpha: A key regulator of energy metabolism. Adv. Physiol. Educ. 2006;30:145&#x2013;151. doi: 10.1152/advan.00052.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/advan.00052.2006</ArticleId><ArticleId IdType="pubmed">17108241</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Marcos P.J., Auwerx J. Regulation of PGC-1&#x3b1;, a nodal regulator of mitochondrial biogenesis. Am. J. Clin. Nutr. 2011;93:884S&#x2013;890S. doi: 10.3945/ajcn.110.001917.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.110.001917</ArticleId><ArticleId IdType="pmc">PMC3057551</ArticleId><ArticleId IdType="pubmed">21289221</ArticleId></ArticleIdList></Reference><Reference><Citation>Romanello V., Guadagnin E., Gomes L., Roder I., Sandri C., Petersen Y., Milan G., Masiero E., Del Piccolo P., Foretz M., et al. Mitochondrial fission and remodelling contributes to muscle atrophy. EMBO J. 2010;29:1774&#x2013;1785. doi: 10.1038/emboj.2010.60.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.60</ArticleId><ArticleId IdType="pmc">PMC2876965</ArticleId><ArticleId IdType="pubmed">20400940</ArticleId></ArticleIdList></Reference><Reference><Citation>Onishi M., Yamano K., Sato M., Matsuda N., Okamoto K. Molecular mechanisms and physiological functions of mitophagy. EMBO J. 2021;40:e104705. doi: 10.15252/embj.2020104705.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020104705</ArticleId><ArticleId IdType="pmc">PMC7849173</ArticleId><ArticleId IdType="pubmed">33438778</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharpe A.J., McKenzie M. Mitochondrial fatty acid oxidation disorders associated with short-chain enoyl-CoA hydratase (ECHS1) deficiency. Cells. 2018;7:46. doi: 10.3390/cells7060046.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells7060046</ArticleId><ArticleId IdType="pmc">PMC6025059</ArticleId><ArticleId IdType="pubmed">29882869</ArticleId></ArticleIdList></Reference><Reference><Citation>Rambold A.S., Kostelecky B., Elia N., Lippincott-Schwartz J. Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation. Proc. Natl. Acad. Sci. USA. 2011;108:10190&#x2013;10195. doi: 10.1073/pnas.1107402108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1107402108</ArticleId><ArticleId IdType="pmc">PMC3121813</ArticleId><ArticleId IdType="pubmed">21646527</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Huang Q., Long X., Guo X., Sun X., Jin X., Li Z., Ren T., Yuan P., Huang X., et al. Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress. Oncogene. 2017;36:4901&#x2013;4912. doi: 10.1038/onc.2017.98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2017.98</ArticleId><ArticleId IdType="pubmed">28436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Tondera D., Grandemange S., Jourdain A., Karbowski M., Mattenberger Y., Herzig S., Da Cruz S., Clerc P., Raschke I., Merkwirth C., et al. SLP-2 is required for stress-induced mitochondrial hyperfusion. EMBO J. 2009;28:1589&#x2013;1600. doi: 10.1038/emboj.2009.89.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2009.89</ArticleId><ArticleId IdType="pmc">PMC2693158</ArticleId><ArticleId IdType="pubmed">19360003</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle D.M., Kim-Schulze S., Huang H.H., Beckmann N.D., Nirenberg S., Wang B., Lavin Y., Swartz T.H., Madduri D., Stock A., et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 2020;26:1636&#x2013;1643. doi: 10.1038/s41591-020-1051-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1051-9</ArticleId><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D., Nilsson-Payant B.E., Liu W.C., Uhl S., Hoagland D., M&#xf8;ller R., Jordan T.X., Oishi K., Panis M., Sachs D., et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181:1036&#x2013;1045.e1039. doi: 10.1016/j.cell.2020.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva R.P., Goncalves J.I.B., Zanin R.F., Schuch F.B., de Souza A.P.D. Circulating type I interferon levels and COVID-19 Severity: A systematic review and Meta-analysis. Front. Immunol. 2021;12:657363. doi: 10.3389/fimmu.2021.657363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.657363</ArticleId><ArticleId IdType="pmc">PMC8149905</ArticleId><ArticleId IdType="pubmed">34054820</ArticleId></ArticleIdList></Reference><Reference><Citation>Contoli M., Papi A., Tomassetti L., Rizzo P., Vieceli Dalla Sega F., Fortini F., Torsani F., Morandi L., Ronzoni L., Zucchetti O., et al. Blood Interferon-alpha levels and severity, outcomes, and inflammatory profiles in hospitalized COVID-19 patients. Front. Immunol. 2021;12:648004. doi: 10.3389/fimmu.2021.648004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.648004</ArticleId><ArticleId IdType="pmc">PMC7985458</ArticleId><ArticleId IdType="pubmed">33767713</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G., Bortolasci C.C., Puri B.K., Marx W., O&#x2019;Neil A., Athan E., Walder K., Berk M., Olive L., Carvalho A.F., et al. The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all? Cytokine. 2021;144:155593. doi: 10.1016/j.cyto.2021.155593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2021.155593</ArticleId><ArticleId IdType="pmc">PMC8149193</ArticleId><ArticleId IdType="pubmed">34074585</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano G.S., Woods J.K., Amato A.A. Covid-19-associated myopathy caused by type I interferonopathy. N. Engl. J. Med. 2020;383:2389&#x2013;2390. doi: 10.1056/NEJMc2031085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2031085</ArticleId><ArticleId IdType="pmc">PMC7722689</ArticleId><ArticleId IdType="pubmed">33216474</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens S., Hendrickx P., Snijders T., Lambrichts I., Stessel B., Dubois J., van Loon L.J.C., Vandenabeele F., Agten A. Skeletal muscles of patients infected with SARS-CoV-2 develop severe myofiber damage upon one week of admission on the intensive care unit. Appl. Sci. 2022;12:7310. doi: 10.3390/app12147310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app12147310</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubowitz V., Sewry C.A., Oldfors A. Muscle Biopsy: A Practical Approach. 5th ed. Elsevier; Amsterdam, The Netherlands: 2020.</Citation></Reference><Reference><Citation>Gordon D.E., Jang G.M., Bouhaddou M., Xu J., Obernier K., White K.M., O&#x2019;Meara M.J., Rezelj V.V., Guo J.Z., Swaney D.L., et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583:459&#x2013;468. doi: 10.1038/s41586-020-2286-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2286-9</ArticleId><ArticleId IdType="pmc">PMC7431030</ArticleId><ArticleId IdType="pubmed">32353859</ArticleId></ArticleIdList></Reference><Reference><Citation>Stukalov A., Girault V., Grass V., Karayel O., Bergant V., Urban C., Haas D.A., Huang Y., Oubraham L., Wang A., et al. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature. 2021;594:246&#x2013;252. doi: 10.1038/s41586-021-03493-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03493-4</ArticleId><ArticleId IdType="pubmed">33845483</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarnieri J.W., Dybas J.M., Fazelinia H., Kim M.S., Frere J., Zhang Y., Soto Albrecht Y., Murdock D.G., Angelin A., Singh L.N., et al. Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts. Sci. Transl. Med. 2023;15:eabq1533. doi: 10.1126/scitranslmed.abq1533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq1533</ArticleId><ArticleId IdType="pubmed">37556555</ArticleId></ArticleIdList></Reference><Reference><Citation>Thoma A., Lightfoot A.P. NF-kB and inflammatory cytokine signaling: Role in skeletal muscle atrophy. Adv. Exp. Med. Biol. 2018;1088:267&#x2013;279. doi: 10.1007/978-981-13-1435-3_12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-13-1435-3_12</ArticleId><ArticleId IdType="pubmed">30390256</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandri M. Signaling in muscle atrophy and hypertrophy. Physiology. 2008;23:160&#x2013;170. doi: 10.1152/physiol.00041.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiol.00041.2007</ArticleId><ArticleId IdType="pubmed">18556469</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartori R., Romanello V., Sandri M. Mechanisms of muscle atrophy and hypertrophy: Implications in health and disease. Nat. Commun. 2021;12:330. doi: 10.1038/s41467-020-20123-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20123-1</ArticleId><ArticleId IdType="pmc">PMC7803748</ArticleId><ArticleId IdType="pubmed">33436614</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang C.H., Frost R.A., Nairn A.C., MacLean D.A., Vary T.C. TNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation. Am. J. Physiol. Endocrinol. Metab. 2002;282:E336&#x2013;E347. doi: 10.1152/ajpendo.00366.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00366.2001</ArticleId><ArticleId IdType="pubmed">11788365</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.P., Chen Y., John J., Moylan J., Jin B., Mann D.L., Reid M.B. TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J. 2005;19:362&#x2013;370. doi: 10.1096/fj.04-2364com.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.04-2364com</ArticleId><ArticleId IdType="pmc">PMC3099533</ArticleId><ArticleId IdType="pubmed">15746179</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell A., Hepgul N., Nikkheslat N., Borsini A., Zajkowska Z., Moll N., Forton D., Agarwal K., Chalder T., Mondelli V., et al. Persistent fatigue induced by interferon-alpha: A novel, inflammation-based, proxy model of chronic fatigue syndrome. Psychoneuroendocrinology. 2019;100:276&#x2013;285. doi: 10.1016/j.psyneuen.2018.11.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2018.11.032</ArticleId><ArticleId IdType="pmc">PMC6350004</ArticleId><ArticleId IdType="pubmed">30567628</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>